Number of filled vials doubled in 2020

Hamburg / Dassow, January 1st, 2021

AqVida had a good 2020 despite all the imponderables.

The stable, slightly growing foreign demand and increased domestic demand have led to the number of filled vials in the company's own production facility being doubled. Especially during the COVID19 pandemic, the location in Germany brought advantages, as supply chains from abroad were often slowed down or even interrupted.

After bottled liters, paclitaxel was the most important product, followed by epirubicin.

For the year 2021, the company sees further opportunities to increase the number of filled vials.

We are available for current company topics and interview requests:

Saskia Heinze

Claudia Schubert

Telephone:

49 (0) 40 / 380 371 9 - 0



Mail: pr@aqvida.com